Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | DYRK1A |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → DYRK1A |
| (<<) CDK5 → DYRK1A |
| (<<) CENPF → DYRK1A |
| (<<) CXADR → DYRK1A |
| (<<) DUSP10 → DYRK1A |
| (<<) E2F7 → DYRK1A |
| (<<) ELF4 → DYRK1A |
| (<<) EPHA4 → DYRK1A |
| (<<) FGF5 → DYRK1A |
| (<<) FZD7 → DYRK1A |
| (<<) GLRX → DYRK1A |
| (<<) HDAC11 → DYRK1A |
| (<<) ILK → DYRK1A |
| (<<) INE1 → DYRK1A |
| (<<) NDOR1 → DYRK1A |
| (<<) PLCG1 → DYRK1A |
| (<<) PTMA → DYRK1A |
| (<<) RBM7 → DYRK1A |
| (<<) RRAS → DYRK1A |
| (<<) SPR → DYRK1A |
| (<<) SPRR2G → DYRK1A |
| (<<) STAM2 → DYRK1A |
| (<<) TAF9 → DYRK1A |
| Downstream (Children) |
|---|
| DYRK1A → ELF3 (>>) |
| DYRK1A → ENO3 (>>) |
| DYRK1A → ETS2 (>>) |
| DYRK1A → ORM1 (>>) |
| DYRK1A → S100P (>>) |
